To determine the effect of NF-κB inhibition induced CD44 repression on breast cancer cell properties, we first examined cell morphology (e.g., size and CD44 staining pattern) after Bay-11-7082 treatment to determine if the cells were healthy after treatment. Here, CD44 is linked to breast cancer.